BALOGLU, Erkan E,SHACHAM, Sharon S,SENAPEDIS, William W,MCCAULEY, Dilara D,LANDESMAN, Yosef Y,GOLAN, Gali G,KALID, Ori O,SHECHTER, Sharon S,.巴羅格魯,.沙查姆,.塞納佩迪斯,.麥考利,.蘭德斯曼,.格蘭,.卡利德,.謝克特爾
申请号：
HK16112275.3
公开号：
HK1223937A
申请日:
2016.10.25
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula A, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
